Pure Global

Novax Pharma Navilipo Eye Drops - HSA Registration DE0505205

Access comprehensive regulatory information for Novax Pharma Navilipo Eye Drops in the Singapore medical device market through Pure Global AI's free database. This CLASS B medical device is registered under HSA registration number DE0505205 and owned by Novax Pharma S.A.M. The device was registered on December 07, 2020.

This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.

Free Database
Powered by Pure Global AI
HSA Official Data
CLASS B
DE0505205
Novax Pharma Navilipo Eye Drops
HSA Registration Number: DE0505205
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Product Description

Navi®Lipo eye drops helps restoring the ocular surface microenvironment altered by the increased tendency to evaporate, instability of tear film, traumas, ocular surgery, wearing contact lenses, staring at a computer or smartphone screen for a long time

Device Classification
Device Class
CLASS B
Medical Speciality Area
Ophthalmology
Registration Information
Registration Number
DE0505205
Registration Date
December 07, 2020
Change Notification Approval Date
November 18, 2022
Retention Due Date
December 06, 2025
Product Owner
Short Name
Novax Pharma S.A.M
Address
Le Coronado 20, avenue de Fontvieille, 98000 Monaco, MONACO
Registrant
Address
1 YISHUN INDUSTRIAL STREET 1, A'POSH BIZHUB, #03-32, SINGAPORE 768160
Importer
Address
1 YISHUN INDUSTRIAL STREET 1, A'POSH BIZHUB, #03-32, SINGAPORE 768160
Model Information
Model Name(s)
Novax Pharma Navilipo Eye Drops 10ml Novax Pharma Navilipo Eye Drops 3ml
Model Identifier(s)
D10NL348 D3NL349